| B19V | Parvovirus B19 |
| CPV-2 | Canine Parvovirus type 2 |
| COVID-19 | Coronavirus disease 2019 |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| DNA | Deoxyribonucleic acid |
| PLA2 | Phospholipase A2 |
| TfR1 | Transferrin receptor 1 |
| NS1 | Non-structural protein 1 |
| 11 kDa | 11-kilodalton non-structural protein |
| mRNA | Messenger ribonucleic acid |
| cTnI | Cardiac troponin I |
| CMR | Cardiovascular magnetic resonance |
| EMB | Endomyocardial biopsy |
| IHC | Immunohistochemistry |
| ISH | In situ hybridisation |
| LGE | Late gadolinium enhancement |
| HF | Heart failure |
| DCM | Dilated cardiomyopathy |
| GLS | Global longitudinal strain |
| Tei index | Myocardial performance index (Tei index) |
| PCR | Polymerase chain reaction |
| RT-qPCR | Reverse transcription quantitative PCR |
| VP | Viral protein |
| VP1 | Viral protein 1 |
| VP2 | Viral protein 2 |
| VP1u | Viral protein unique region |